Related Experiment Video
Updated: May 11, 2026

Engineering of Human Blood-Induced Microglia-like Cells for Reverse-Translational Brain Research
Published on: September 6, 2024
Microglial dysregulation in psychiatric disease
Luciana Romina Frick1, Kyle Williams, Christopher Pittenger
1Department of Psychiatry, Yale University School of Medicine, 34 Park Street, W315, New Haven, CT 06519, USA.
Abstract:
Microglia, the brain's resident immune cells, are phagocytes of the macrophage lineage that have a key role in responding to inflammation and immune challenge in the brain. More recently, they have been shown to have a number of important roles beyond immune surveillance and response, including synaptic pruning during development and the support of adult neurogenesis. Microglial abnormalities have been found in several neuropsychiatric conditions, though in most cases it remains unclear whether these are causative or are a reaction to some other underlying pathophysiology. Here we summarize postmortem, animal, neuroimaging, and other evidence for microglial pathology in major depression, schizophrenia, autism, obsessive-compulsive disorder, and Tourette syndrome. We identify gaps in the existing literature and important areas for future research. If microglial pathology proves to be an important causative factor in these or other neuropsychiatric diseases, modulators of microglial function may represent a novel therapeutic strategy.
Insights
Microglia, brain immune cells, show abnormalities in major neuropsychiatric disorders. Further research is needed to determine if these microglial changes are a cause or effect, potentially leading to new therapies.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Microglia are brain-resident immune cells crucial for neural health.
- Beyond immune surveillance, microglia regulate synaptic plasticity and neurogenesis.
- Abnormalities in microglia are observed in various neuropsychiatric conditions, but their causal role is unclear.
Purpose of the Study:
- To review evidence of microglial pathology in major depression, schizophrenia, autism, OCD, and Tourette syndrome.
- To identify knowledge gaps and future research directions concerning microglia in neuropsychiatric diseases.
Main Methods:
- Summary of postmortem studies.
- Analysis of animal models.
- Review of neuroimaging data.
- Inclusion of other relevant evidence.
Main Results:
- Evidence suggests microglial pathology across multiple neuropsychiatric disorders.
- The precise role of microglia (causative vs. reactive) remains to be fully elucidated.
- Significant gaps exist in understanding microglial involvement in these conditions.
Conclusions:
- Microglial dysfunction is implicated in major neuropsychiatric disorders.
- Further research is essential to clarify the causative role of microglial pathology.
- Targeting microglial function presents a potential novel therapeutic avenue for neuropsychiatric diseases.
Related Concept Videos
Gut-Brain Axis
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Neural Regulation
Parkinson Disease ll: Pathophysiology
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
